Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 2
2005 3
2006 3
2007 1
2008 7
2009 2
2010 10
2011 5
2012 12
2013 7
2014 13
2015 4
2016 3
2017 5
2018 2
2019 2
2020 7
2021 5
2022 7
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
Horn L, Mansfield AS, Szczęsna A, Havel L, Krzakowski M, Hochmair MJ, Huemer F, Losonczy G, Johnson ML, Nishio M, Reck M, Mok T, Lam S, Shames DS, Liu J, Ding B, Lopez-Chavez A, Kabbinavar F, Lin W, Sandler A, Liu SV; IMpower133 Study Group. Horn L, et al. Among authors: krzakowski m. N Engl J Med. 2018 Dec 6;379(23):2220-2229. doi: 10.1056/NEJMoa1809064. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280641 Clinical Trial.
Lung Cancer in Poland.
Adamek M, Biernat W, Chorostowska-Wynimko J, Didkowska JA, Dziadziuszko K, Grodzki T, Jassem J, Kępka L, Kowalski D, Krawczyk P, Krzakowski M, Nikliński J, Langfort R, Olszewski W, Orłowski T, Ramlau R, Rzyman W, Wrona A, Zieliński M, Dziadziuszko R. Adamek M, et al. Among authors: krzakowski m. J Thorac Oncol. 2020 Aug;15(8):1271-1276. doi: 10.1016/j.jtho.2020.03.035. J Thorac Oncol. 2020. PMID: 32718535 Free article. No abstract available.
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M, Kaiser R, Mellemgaard A, Douillard JY, Orlov S, Krzakowski M, von Pawel J, Gottfried M, Bondarenko I, Liao M, Gann CN, Barrueco J, Gaschler-Markefski B, Novello S; LUME-Lung 1 Study Group. Reck M, et al. Among authors: krzakowski m. Lancet Oncol. 2014 Feb;15(2):143-55. doi: 10.1016/S1470-2045(13)70586-2. Epub 2014 Jan 9. Lancet Oncol. 2014. PMID: 24411639 Free article. Clinical Trial.
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Liu SV, Mok TSK, Nabet BY, Mansfield AS, De Boer R, Losonczy G, Sugawara S, Dziadziuszko R, Krzakowski M, Smolin A, Hochmair MJ, Garassino MC, Gay CM, Heymach JV, Byers LA, Lam S, Cardona A, Morris S, Adler L, Shames DS, Reck M. Liu SV, et al. Among authors: krzakowski m. Lung Cancer. 2023 Dec;186:107418. doi: 10.1016/j.lungcan.2023.107418. Epub 2023 Oct 31. Lung Cancer. 2023. PMID: 37931445 Free article. Clinical Trial.
Immune checkpoint inhibitors combined with tyrosine kinase inhibitors or immunotherapy for treatment-naïve metastatic clear-cell renal cell carcinoma-A network meta-analysis. Focus on cabozantinib combined with nivolumab.
Niewada M, Macioch T, Konarska M, Mela A, Goszczyński A, Przekopińska B, Rajkiewicz K, Wysocki P, Krzakowski M. Niewada M, et al. Among authors: krzakowski m. Front Pharmacol. 2023 Mar 3;13:1063178. doi: 10.3389/fphar.2022.1063178. eCollection 2022. Front Pharmacol. 2023. PMID: 36937206 Free PMC article.
Savolitinib for non-small cell lung cancer.
Zaborowska-Szmi M, Szmit S, Krzakowski M, Kowalski DM. Zaborowska-Szmi M, et al. Among authors: krzakowski m. Drugs Today (Barc). 2023 Jan;59(1):17-36. doi: 10.1358/dot.2023.59.1.3425324. Drugs Today (Barc). 2023. PMID: 36811415
108 results